o NoneEntity Type
0000832489
Geovax Labs, Inc.
DAUPHIN TECHNOLOGY INC
SUCCESSO INC
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 GeoVax Labs, Inc.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 GeoVax Labs, Inc. 
Street Address 1Street Address 2
 1900 LAKE PARK DRIVE SUITE 380
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 SMYRNA GEORGIA 30080 678-384-7220 



3. Related Persons
Last NameFirst NameMiddle Name
McNallyRobertT.
Street Address 1Street Address 2
c/o GeoVax, Inc.1900 Lake Park Drive, Suite 380
CityState/Province/CountryZIP/Postal Code
SmyrnaGEORGIA30080
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
DoddDavidA.
Street Address 1Street Address 2
c/o GeoVax, Inc.1900 Lake Park Drive, Suite 380
CityState/Province/CountryZIP/Postal Code
SmyrnaGEORGIA30080
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ReynoldsMarkW.
Street Address 1Street Address 2
c/o GeoVax, Inc.1900 Lake Park Drive, Suite 380
CityState/Province/CountryZIP/Postal Code
SmyrnaGEORGIA30080
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
Spencer, Jr.JohnN.
Street Address 1Street Address 2
c/o GeoVax, Inc.1900 Lake Park Drive, Suite 380
CityState/Province/CountryZIP/Postal Code
SmyrnaGEORGIA30080
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
KollintzasDeanG.
Street Address 1Street Address 2
c/o GeoVax, Inc.1900 Lake Park Drive, Suite 380
CityState/Province/CountryZIP/Postal Code
SmyrnaGEORGIA30080
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ChaseRandalD.
Street Address 1Street Address 2
c/o GeoVax, Inc.1900 Lake Park Drive, Suite 380
CityState/Province/CountryZIP/Postal Code
SmyrnaGEORGIA30080
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
NewmanMarkJ.
Street Address 1Street Address 2
c/o GeoVax, Inc.1900 Lake Park Drive, Suite 380
CityState/Province/CountryZIP/Postal Code
SmymaGEORGIA30080
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   x Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  o Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2021-02-11 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
  
(Associated) Broker or Dealer o None(Associated) Broker or Dealer CRD Number o None
  
Street Address 1Street Address 2
  
City State/Province/CountryZIP/Postal Code
   
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 495000 USD o Indefinite
Total Amount Sold $ 495000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 1


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 0 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
GeoVax Labs (NASDAQ:GOVX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more GeoVax Labs Charts.
GeoVax Labs (NASDAQ:GOVX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more GeoVax Labs Charts.

Geovax Labs, Inc. News

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine
Friday 5 April 2024 (1 month ago) • GlobeNewswire Inc.
GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress
Friday 29 March 2024 (1 month ago) • GlobeNewswire Inc.
GeoVax to Present at the 36th Annual Roth Conference
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.
Form S-3 - Registration statement under Securities Act of 1933
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)
GeoVax Reports 2023 Year-End Financial Results and Provides Business Update
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)
GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024
Friday 23 February 2024 (2 months ago) • GlobeNewswire Inc.
GeoVax to Present at the 2024 BIO CEO & Investor Conference
Tuesday 20 February 2024 (3 months ago) • GlobeNewswire Inc.

More Geovax Labs, Inc. News Articles